Provided by Tiger Trade Technology Pte. Ltd.

Repligen

174.73
+6.734.01%
Post-market: 177.983.25+1.86%18:55 EDT
Volume:891.26K
Turnover:155.19M
Market Cap:9.84B
PE:239.36
High:175.86
Open:168.27
Low:168.27
Close:168.00
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:1.04
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.66
PE(LYR):203.17

Loading ...

Movement Alert|Repligen Corporation Rises 6.57% in Regular Trading, Trading at $147.26

Market Focus
·
Jun 26

Is Q1 Beat And Reaffirmed 2026 Guidance Altering The Investment Case For Repligen (RGEN)?

Simply Wall St.
·
Jun 15

Repligen (RGEN) Stock Valuation After RBC Coverage Resumes And Q1 2026 Beat

Simply Wall St.
·
Jun 14

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN), Vaxcyte (PCVX) and BeOne Medicines (ONC)

TIPRANKS
·
Jun 04

Repligen posts investor presentation outlining bioprocessing growth strategy, margin expansion path

Reuters
·
Jun 04

U.S. RESEARCH ROUNDUP-Aveanna Healthcare, Palo Alto, Ulta Beauty

Reuters
·
Jun 03

Repligen Coverage Assumed by Wolfe Research at Outperform

Dow Jones
·
Jun 02

Repligen assumed with an Outperform at Wolfe Research

TIPRANKS
·
Jun 02

Repligen CEO Loeillot presents at William Blair Growth Stock Conference

Reuters
·
May 22

Repligen publishes 2025 corporate sustainability report

Reuters
·
May 20

Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report

GlobeNewswire
·
May 20

Q/C Technologies Q1 net loss widens to USD 1.24 million

Reuters
·
May 16

Repligen Likely to Benefit From Diverse Growth Factors, RBC Says

MT Newswires Live
·
May 16

Repligen Price Target Announced at $160.00/Share by RBC Capital

Dow Jones
·
May 15

U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific

Reuters
·
May 15

Repligen Corp : RBC Resumes Coverage With Outperform Rating; Target Price $160

THOMSON REUTERS
·
May 15

Q/C Technologies director Chelsea Sierra Voss acquires 1,753 shares for $5,521.95

Reuters
·
May 15

Repligen resumed with an Outperform at RBC Capital

TIPRANKS
·
May 15

Alphabet Reports Stake In PayPay And CME Group, Dissolves In Dexcom

Reuters
·
May 08

Guggenheim Reaffirms Their Hold Rating on Repligen (RGEN)

TIPRANKS
·
May 08